Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-099836
Filing Date
2024-11-19
Accepted
2024-11-19 08:00:52
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0221540-10q_regenerative.htm   iXBRL 10-Q 780249
2 CERTIFICATION ea022154001ex31-1_regener.htm EX-31.1 10199
3 CERTIFICATION ea022154001ex31-2_regener.htm EX-31.2 10329
4 CERTIFICATION ea022154001ex32-1_regener.htm EX-32.1 4704
  Complete submission text file 0001213900-24-099836.txt   5704474

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mssv-20240930.xsd EX-101.SCH 47790
6 XBRL CALCULATION FILE mssv-20240930_cal.xml EX-101.CAL 35896
7 XBRL DEFINITION FILE mssv-20240930_def.xml EX-101.DEF 274976
8 XBRL LABEL FILE mssv-20240930_lab.xml EX-101.LAB 451885
9 XBRL PRESENTATION FILE mssv-20240930_pre.xml EX-101.PRE 285335
73 EXTRACTED XBRL INSTANCE DOCUMENT ea0221540-10q_regenerative_htm.xml XML 572852
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 800-889-9509
Regenerative Medical Technology Group Inc. (Filer) CIK: 0001760026 (see all company filings)

EIN.: 880492191 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56010 | Film No.: 241473399
SIC: 5990 Retail-Retail Stores, NEC
(CF Office: 07 Trade & Services)